6-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S454000, C549S060000, C549S365000, C549S404000

Reexamination Certificate

active

07368575

ABSTRACT:
When a multi-step process reaction is carried out in a solution, it generally requires several treatments and purification procedures to go through with after the reaction, however, the inventive method for preparing 2,2′-disubstituted-3,4-dihydro-7,8-disubstituted-6-amino benzopyran derivative using a solid-phased synthetic method simplifies the treatment and purification procedures after the reaction, which makes possible to efficiently construct numerous drug-like libraries. In particular, since the inventive method of the present invention comprises the steps of introducing a carbonate linker of formula 2 into Wang resin used as a common solid support (Step 1); synthesizing various benzopyran in a carbamate form of formula 3 as a key intermediate by reacting various amino benzopyran derivatives with the carbamate resin of formula 2 (Step 2); synthesizing 2,2′-disubstituted-3,4-2H-6-substituted benzopyran resin of formula 4 (Step 3); and synthesizing 2,2′-disubstituted-3,4-2H-6-alkylamino benzopyran derivative of formula 1 using a dichloromethane solution containing TFA or an organic solvent containing an organic acid, the inventive method is capable of efficiently synthesizing various 2,2′-disubstituted-3,4-2H-6-alkylamino benzopyran derivatives.Consequently, the present invention has developed a new technique for constructing 2,2′-disubstituted-3,4-2H-6-alkylamino benzopyran library using a solid-phase parallel synthetic method and makes increased the applicability of combinatorial chemical synthetic method. Further, 2,2′-disubstituted-3,4-2H-6-alkylamino benzopyran derivative prepared by the inventive method has a high inhibitory effect to 5-lipoxygenase (5-LO) activity, and therefore, can be effectively used for developing a new propylactic or therapeutic drug for leukotriene activation-related diseases such as chronic inflammation, rheumatic arthritis, colitis, asthma and psoriasis.

REFERENCES:
patent: 5646308 (1997-07-01), Koga et al.
patent: 5696137 (1997-12-01), Heine et al.
patent: 6395909 (2002-05-01), Bell et al.
patent: 176157 (1997-09-01), None
patent: WO87/05020 (1987-08-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

6-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2773807

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.